Product Information
NBI 42902 is a drug that has been shown to inhibit the uptake of aliphatic hydrocarbons. This inhibition may be due to its ability to act as a potent antagonist of the β-receptor and/or the hydroxy derivative. NBI 42902 was found to have antitumor properties in humans, but not in animals. The drug also has an effect on endometriosis, which may be due to its inhibition of prostaglandin synthesis. NBI 42902 is orally active and binds to receptors in the body, including those for cancerous cells.
Chemical properties
Technical inquiry about: 3D-FN103814 NBI 42902
If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.
